Methotrexate-associated intravascular large B-cell lymphoma in a patient with rheumatoid arthritis

Jun Kikuchi, Yuko Kaneko, Hidenori Kasahara, Katsura Emoto, Akiharu Kubo, Shinichiro Okamoto, Tsutomu Takeuchi

研究成果: Article査読

9 被引用数 (Scopus)

抄録

Intravascular large B-cell lymphoma (IVLBCL) is a rare and clinically aggressive lymphoma with an unfavorable prognosis. We report the case of a 50-year-old woman who was diagnosed with IVLBCL during treatment with methotrexate (MTX) and biologic agents for rheumatoid arthritis. The symptoms showed partial improvement only after the cessation of both treatments. She subsequently received chemotherapy and achieved a complete remission and has remained free of recurrence for 2 years without any further treatment. We herein describe a rare case of IVLBCL which presented with the features of an MTX-associated lymphoproliferative disorder.

本文言語English
ページ(範囲)1661-1665
ページ数5
ジャーナルInternal Medicine
55
12
DOI
出版ステータスPublished - 2016

ASJC Scopus subject areas

  • Internal Medicine

フィンガープリント 「Methotrexate-associated intravascular large B-cell lymphoma in a patient with rheumatoid arthritis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル